Grey Mark Pharmaceuticals Private Limited
About Grey Mark Pharmaceuticals Private Limited
Data last updated:
Grey Mark Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 29 September 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74994MH2017PTC300257.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jaihind Kharpat Sahani and Ranjeet Sharma.
Its last annual general meeting (AGM) was held on 30 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office is at 4/306 Vithal Nagar Society Behind Ambrosia Tower Devipada Borival East, Mumbai, Maharashtra, India – 400066.
As per the financials filed for FY 2018, the company reported a revenue of ₹4.69 Lakh. For the same year it recorded a net loss of ₹4.67 Lakh (net margin -99.6%) and EBITDA of -₹4.67 Lakh (EBITDA margin -99.6%).
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Grey Mark Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra.
- Registered Address4/306 Vithal Nagar Society Behind Ambrosia Tower Devipada Borival East, Mumbai, Maharashtra, India – 400066
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Grey Mark Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Grey Mark Pharmaceuticals Private Limited, buy the company report.
Financials of Grey Mark Pharmaceuticals Private Limited
FY 2018 filings availableGrey Mark Pharmaceuticals Private Limited reported revenue of ₹4.69 Lakh for FY 2018.
Financial Statement Summary
| Metrics | FY 2017-18 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | -₹4.67 Lakh |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹4.67 Lakh |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2017-18 |
|---|---|
| Profitability | |
| EBITDA Margin | -99.6% |
| Net Profit Margin | -99.6% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Grey Mark Pharmaceuticals Private Limited, buy the company report.
Board of directors of Grey Mark Pharmaceuticals Private Limited
Grey Mark Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jaihind Kharpat Sahani Also directs: Arhar Enterprises Private Limited | Director | 29 Sep 2017 | 9 Years 0 Months | Current |
| Ranjeet Sharma | Director | 10 Nov 2021 | 4 Years 11 Months | Current |
Peer comparison
Grey Mark Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cleancare Pharmaceuticals Private Limited | ₹4.7 Lakh (FY 2021) | Delhi, India | ||||
| Grey Mark Pharmaceuticals Private Limitedthis company | ₹4.69 Lakh (FY 2018) | -₹4.67 Lakh | -99.6% | Mumbai, Maharashtra, India | ||
| Elanz Pharmaceuticals Private Limited | ₹4.69 Lakh (FY 2025) | -65.0% | Ahmedabad, Gujarat, India | |||
| Cadmic Pharmaceuticals Private Limited | ₹4.69 Lakh (FY 2022) | Panchkula, Haryana, India | ||||
| Bevan Pharmaceuticals Private Limited | ₹4.68 Lakh (FY 2024) | -39.0% | Patna, Bihar, India |
To see the full peer comparison of Grey Mark Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Grey Mark Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Grey Mark Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Grey Mark Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Grey Mark Pharmaceuticals Private Limited has 5 board changes on record since 2017: 2 appointments and 3 cessations. The latest: Anurag Dubey ceased to be Additional Director on 04 Mar 2022.
Frequently asked questions
Grey Mark Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 29 September 2017 (9+ years old) and is registered under CIN U74994MH2017PTC300257.
Grey Mark Pharmaceuticals has 2 current directors:
- Jaihind Kharpat Sahani - Director
- Ranjeet Sharma - Director
The latest financial statements of Grey Mark Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 30 September 2018. Year-wise statements from FY 2018 are in the company report.
The CIN (Corporate Identification Number) of Grey Mark Pharmaceuticals is U74994MH2017PTC300257. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Grey Mark Pharmaceuticals was incorporated on 29 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Grey Mark Pharmaceuticals by revenue are Cleancare Pharmaceuticals Private Limited, Elanz Pharmaceuticals Private Limited, Cadmic Pharmaceuticals Private Limited, Bevan Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Anurag Dubey ceased to be Additional Director on 04 Mar 2022. Ranjeet Sharma was appointed as Director on 10 Nov 2021. Sanjog Samanpure ceased to be Additional Director on 19 Jan 2019. Grey Mark Pharmaceuticals has 5 board changes on record in total.
The registered office of Grey Mark Pharmaceuticals is at 4306 Vithal Nagar Society Behind Ambrosia Tower Devipada Borival East, Mumbai, Maharashtra, India – 400066.
Grey Mark Pharmaceuticals operates in the business services industry, in the miscellaneous business activities segment.
The compliance status of Grey Mark Pharmaceuticals is active non-compliant as of 04 September 2026. The company is actively filing with the Registrar of Companies.
Grey Mark Pharmaceuticals can be reached at its registered office: 4306 Vithal Nagar Society Behind Ambrosia Tower Devipada Borival East, Mumbai, Maharashtra, India – 400066.